Owl Rock Capital Corporation OBDC 深 滬
等待開盤 01-13 09:30:00 美东时间
12.65
+0.090
+0.72%
華盛通- 最 高12.67
- 今 開12.51
- 成交量 302.19万股
- 最 低 12.48
- 昨 收 12.56
- 總市值 64.64亿
- 52周最高 14.425
- 市盈率 靜 8.29
- 換手率 0.00%
- 52周最低 10.97
- 委 比 -97.59%
- 總股本 5.11亿
- 歷史最高 14.17
- 量 比 0.77
- 振 幅 1.51%
- 歷史最低 -0.87
- 每 手 1
- 風險率 0.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Driving the Market Sentiment Around Blue Owl Capital Corp?
Blue Owl Capital Corp's (NYSE:OBDC) short interest as a percent of float has ri...
2025-12-23 04:00
美股12月收息策略：最高股息率超11%！泰森食品、惠普、英美烟草等超100家高分红股如何布局！
最高股息率超11%！泰森食品、惠普、英美烟草等超100家高分红股如何布局！投资者可在除息前布局，赚取股息！一文速览派息名单>>
2025-12-01 14:00
Alpha Buying: Insurers Warn. Credit Tightens. Insiders Buy Anyway.
If you spend any time in the Business Development Company (BDC) world right now...
2025-11-27 00:20
Blue Owl Capital, Blue Owl Capital Corp. II Announce Merger Termination
Blue Owl Capital Corporation (NYSE:OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") today announced that the previously proposed merger of OBDC and OBDC II has been terminated, with plans to reevaluate
2025-11-19 22:12
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Blue Owl Capital Q3 Adj. EPS $0.36 Misses $0.40 Estimate, Sales $446.307M Miss $467.190M Estimate
Blue Owl Capital (NYSE:OBDC) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.40 by 9.09 percent. This is a 2.86 percent increase over earnings of $0.35 per share from the
2025-11-06 07:08
Blue Owl Capital, Blue Owl Capital Corporation I Sign Merger Agreement
Blue Owl Capital Corporation (NYSE: OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") announced today that they have entered into a definitive merger agreement, with OBDC as the surviving company,
2025-11-06 05:38
Blue Owl Capital Corporation and Blue Owl Capital Corporation II Announce Merger Agreement
Merger of two high-quality, diversified portfolios with substantial investment overlap that enhances scale Will strengthen OBDC's position as the second largest publicly traded BDC by total ...
2025-11-06 05:35
